Persistence of antibodies against middle east respiratory syndrome coronavirus

Emerging Infectious Diseases

Volumn 22, Issue 10, 2016, Pages 1824-1826

  Payne, Daniel C ^a   Iblan, Ibrahim ^b   Rha, Brian ^a   Alqasrawi, Sultan ^c   Haddadin, Aktham ^c   Al Nsour, Mohannad ^d   Alsanouri, Tarek ^c,d   Ali, Sami Sheikh ^c   Harcourt, Jennifer ^a   Miao, Congrong ^a   Tamin, Azaibi ^a   Gerber, Susan I ^a   Haynes, Lia M ^a   Al Abdallat, Mohammad Mousa ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Jordan Ministry of Health ^*  (Jordan)

^c Jordan Ministry of Health   (Jordan)

^d Eastern Mediterranean Public Health Network   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CORONAVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORAX RADIOGRAPHY; BLOOD; EPIDEMIC; IMMUNOLOGY; JORDAN; TIME FACTOR;

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADULT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; FEMALE; HUMANS; JORDAN; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; TIME FACTORS;

EID: 84988528106     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2210.160706     Document Type: Article

References (10)

1. Al-Abdallat MM, Payne DC, Alqaswari S, Rha B, Tohme RA, Abedi GR, et al. Hospital associated outbreak of Middle Eastern respiratory syndrome coronavirus: a serologic, clinical, and epidemiologic description. Clin Infect Dis. 2014;59:1225–33. http://dx.doi.org/10.1093/cid/ciu359
2. Mo H, Zeng G, Ren X, Li H, Ke C, Tan Y, et al. Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology. 2006;11:49–53. http://dx.doi.org/10.1111/j.1440-1843.2006.00783.x
3. Alshukairi AN, Khalid I, Ahmed WA, Dada AM, Bayumi DT, Malic LS, et al. Antibody response and disease severity in healthcare worker MERS survivors. Emerg Infect Dis. 2016;22. http://dx.doi.org/10.3201/eid2206.160010
4. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015;386:995–1007. http://dx.doi.org/10.1016/S0140-6736(15)60454-8
5. Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect. 2015;6:269–78. http://dx.doi.org/10.1016/j.phrp.2015.08.006
6. Lee SI. Costly lessons from the 2015 Middle East respiratory syndrome coronavirus outbreak in Korea. J Prev Med Public Health. 2015;48:274–6. http://dx.doi.org/10.3961/jpmph.15.064
7. Drosten C, Meyer B, Műller MA, Corman VM, Al-Masri M, Hossain R, et al. Transmission of MERS-coronavirus in household contacts. N Engl J Med. 2014;371:828–35. http://dx.doi.org/10.1056/NEJMoa1405858
8. Poon LL, Guan Y, Nicholls JM, Yuen KY, Peiris JS. The aetiology, origins, and diagnosis of severe acute respiratory syndrome. Lancet Infect Dis. 2004;4:663–71. http://dx.doi.org/10.1016/S1473-3099(04)01172-7
9. Corman VM, Albarrak AM, Omrani AS, Albarrak MM, Farah ME, Almasri M, et al. Viral shedding and antibody response in 37 patients with MERS-coronavirus infection. Clin Infect Dis. 2016;62:477–83.
10. Wu LP, Wang NC, Chang YH, Tian XY, Na DY, Zhang LY, et al. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13:1562–4. http://dx.doi.org/10.3201/eid1310.070576